92 related articles for article (PubMed ID: 14640540)
1. Molecular model of the alpha(IIb)beta(3) integrin.
Feuston BP; Culberson JC; Hartman GD
J Med Chem; 2003 Dec; 46(25):5316-25. PubMed ID: 14640540
[TBL] [Abstract][Full Text] [Related]
2. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
Yan Y; Li Y; Zhang S; Ai C
J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
[TBL] [Abstract][Full Text] [Related]
3. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
[TBL] [Abstract][Full Text] [Related]
4. Discrete functional motifs reside within the cytoplasmic tail of alphaV integrin subunit.
Haas TA
Thromb Haemost; 2008 Jan; 99(1):96-107. PubMed ID: 18217140
[TBL] [Abstract][Full Text] [Related]
5. Allosteric regulation of alpha(IIb)beta(3) by beta(3) 95-105.
Haas TA
Thromb Haemost; 2008 Apr; 99(4):701-10. PubMed ID: 18392328
[TBL] [Abstract][Full Text] [Related]
6. A 3D structure model of integrin alpha 4 beta 1 complex: I. Construction of a homology model of beta 1 and ligand binding analysis.
You TJ; Maxwell DS; Kogan TP; Chen Q; Li J; Kassir J; Holland GW; Dixon RA
Biophys J; 2002 Jan; 82(1 Pt 1):447-57. PubMed ID: 11751331
[TBL] [Abstract][Full Text] [Related]
7. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
[TBL] [Abstract][Full Text] [Related]
8. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
9. Human integrin alphavbeta5: homology modeling and ligand binding.
Marinelli L; Gottschalk KE; Meyer A; Novellino E; Kessler H
J Med Chem; 2004 Aug; 47(17):4166-77. PubMed ID: 15293989
[TBL] [Abstract][Full Text] [Related]
10. Studies of the receptor-bound conformation of alphaIIbbeta3 antagonists by 15N-edited NMR spectroscopy.
Locardi E; Mattern RH; Malaney TI; Minasyan R; Pierschbacher MD; Taulane JP; Goodman M
Biopolymers; 2002; 66(5):326-38. PubMed ID: 12539261
[TBL] [Abstract][Full Text] [Related]
11. Factor H binds to platelet integrin alphaIIbbeta3.
Mnjoyan Z; Li J; Afshar-Kharghan V
Platelets; 2008 Nov; 19(7):512-9. PubMed ID: 18979363
[TBL] [Abstract][Full Text] [Related]
12. Glanzmann thrombasthenia: integrin alpha IIb beta 3 deficiency.
Tomiyama Y
Int J Hematol; 2000 Dec; 72(4):448-54. PubMed ID: 11197210
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
14. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
[TBL] [Abstract][Full Text] [Related]
15. Modeling and molecular dynamics of glutamine transaminase K/cysteine conjugate beta-lyase.
Venhorst J; ter Laak AM; Meijer M; van de Wetering I; Commandeur JN; Rooseboom M; Vermeulen NP
J Mol Graph Model; 2003 Sep; 22(1):55-70. PubMed ID: 12798391
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
17. Identity of the amino acid residues involved in C3bi binding to the I-domain supports a mosaic model to explain the broad ligand repertoire of integrin alpha M beta 2.
Ustinov VA; Plow EF
Biochemistry; 2005 Mar; 44(11):4357-64. PubMed ID: 15766265
[TBL] [Abstract][Full Text] [Related]
18. Solution properties of full-length integrin alpha(IIb)beta3 refined models suggest environment-dependent induction of alternative bent /extended resting states.
Rosano C; Rocco M
FEBS J; 2010 Aug; 277(15):3190-202. PubMed ID: 20584077
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
20. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.
Kubota D; Ishikawa M; Yamamoto M; Murakami S; Hachisu M; Katano K; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2089-108. PubMed ID: 16309911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
